Food Allergy clinical trials

Explore recruiting food allergy clinical trials.

Recruiting food allergy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Food Allergy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

EPITOPE Open-label Extension Study to Evaluate the Long-term Clinical Benefit and Safety of DBV712 in Peanut-Allergic Children (EPOPEX)

Germany, Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A three-year, multi-center, double-blind, extension study to evaluate the long-term safety and efficacy of ligelizumab in patients who completed ligelizumab’s Phase III studies in food allergy

Netherlands, France, Spain, Italy, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Sublingual Birch Immunotherapy for Pollen-associated Food Allergy

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Short-Term Linvoseltamab Treatment, on Top of Chronic Dupilumab Treatment, for Adults with Severe Immunoglobulin E (IgE)-Mediated Food Allergy

Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

SHORTEN - Impact of omalizumab withdrawal after a 3 year duration treatment in well controlled severe allergic asthma : a multicentric randomized controlled trial

France

Therapeutic use (Phase IV) EU CTIS Study details

Prospective, open-label study to analyze the efficacy and safety of low-dose oral immunotherapy in children with severe IgE-mediated cow's milk allergy treated with omalizumab. ILO study.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Food Allergy trials by city

Food Allergy in Toronto Food Allergy in Vancouver Food Allergy in Montreal Food Allergy in Calgary Food Allergy in Edmonton Food Allergy in Ottawa Food Allergy in Winnipeg Food Allergy in Quebec City Food Allergy in Hamilton Food Allergy in Kitchener Food Allergy in London Food Allergy in Halifax Food Allergy in New York Food Allergy in Los Angeles Food Allergy in Chicago Food Allergy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease